Treatment of Tinea Corporis
For tinea corporis, first-line treatment is topical antifungal therapy for 2-4 weeks, while oral antifungals are recommended for extensive, resistant, or recurrent infections. 1, 2, 3
Diagnosis
- Confirm diagnosis through:
Treatment Algorithm
First-Line Treatment: Topical Antifungals
- Apply for 2-4 weeks and continue for at least 1 week after clinical clearing 1, 4
- Effective options include:
Second-Line Treatment: Oral Antifungals
Indications for oral therapy:
Recommended oral regimens:
Comparative Efficacy
- Topical terbinafine 1% has shown superior efficacy (94% mycological cure) compared to ketoconazole 2% cream (69% cure) in a one-week treatment course 6
- For oral therapy in resistant cases, itraconazole has demonstrated superior efficacy (66% cure rate) compared to fluconazole (42%), terbinafine (28%), and griseofulvin (14%) 1
Special Considerations
- Inflamed lesions: Consider agents with anti-inflammatory properties or short-term combination antifungal/steroid agents (use with caution due to risk of atrophy) 4
- Children: Griseofulvin is generally well-tolerated with extensive safety data in children 1
- Treatment duration: Continue treatment until at least one week after clinical resolution 1, 4
Prevention and Control
- Screen and treat all household members for anthropophilic infections 1
- Avoid sharing personal items (combs, brushes, clothing) 1
- Apply antifungal powders to prevent reinfection 1
- Maintain good hygiene to control sources of reinfection 2
Common Pitfalls
- Misdiagnosis: Tinea corporis can mimic other annular lesions like pityriasis rosea, leading to inappropriate treatment 1, 3
- Inadequate treatment duration: Stopping treatment too early can lead to recurrence; continue for at least one week after clinical clearing 1, 4
- Prior steroid use: Can modify clinical appearance and make diagnosis difficult 3
- Failure to address reinfection sources: All infected family members should be treated simultaneously 1
- Inappropriate use of oral therapy: Reserve for extensive or resistant cases, as topical therapy is usually sufficient for localized infections 4, 3